Clinical Trials in Baltimore

Showing 10141-10160 of 17,842 trials

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer

NCT03351231

The purpose of this study is to investigate safety of experimental medication BMS-986242 and Nivolumab in patients with advanced cancers.

Cancer

Bristol-Myers Squibb7 participantsStarted Nov 2017

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

NCT01610284

This study was a multi-center, randomized, double-blind, placebo controlled Phase III study to determine the efficacy and safety of treatment with buparlisib plus fulvestrant versus fulvestrant plus placebo in postmenopausal women with hormone Receptor-positive (HR-positive), human epidermal growth factor receptor 2-negative (HER2-negative), locally advanced or metastatic breast cancer (MBC) whose disease has progressed on or after aromatase inhibitor (AI) treatment.

Breast Cancer

Novartis Pharmaceuticals1,147 participantsStarted Aug 2012

Mobile, Alabama, United States • Phoenix, Arizona, United States • Fayetteville, Arkansas, United States +265 more locations

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

Find Trials by Condition in Baltimore

G-POEM for Treatment of Refractory Gastroparesis

Evaluation of Splinting in Tetraplegia

e-CHEC-uP: Scaling up an Efficacious Cancer Screening Intervention for Women With Limited English

Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Blood Component Collection From Patients With Rheumatic or Kidney Disease and Healthy Volunteers

Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor

Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05

A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence

Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration